Oxazorone

Oxazorone

SCHEMBL2109280

O=c1cc(CN2CCOCC2)c2ccc(O)cc2o1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.66
POLB P06746 4/20 0.64
KDM4E B2RXH2 4/20 0.64
GAA P10253 4/20 0.64
HSD17B10 Q99714 2/20 0.62
P4HB P07237 1/20 0.61
KMT2A Q03164 5/20 0.60
MEN1 O00255 4/20 0.60
ALDH1A1 P00352 3/20 0.60
MAPT P10636 3/20 0.60
HPGD P15428 2/20 0.60
GLA P06280 1/20 0.60
HSD17B3 P37058 1/20 0.59
LMNA P02545 2/20 0.58
RECQL P46063 1/20 0.58
ATM Q13315 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA4 P22748 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxazorone SCHEMBL29913823 1.00 TDP1 (0.66) TDP1POLBKDM4EGAAHSD17B10
SCHEMBL28167086 0.87 TDP1 (0.68) TDP1POLBKDM4EGAAHSD17B10
Folescutol SCHEMBL554577 0.84 TDP1 (0.81) TDP1POLBKDM4EGAAHSD17B10
SCHEMBL30507291 0.82 ALDH1A1 (0.70) TDP1POLBKDM4EGAAHSD17B10
SCHEMBL24589796 0.79 KMT2A (0.66) TDP1POLBKDM4EGAAHSD17B10
SCHEMBL3252425 0.78 SIGMAR1 (0.50) TDP1POLBKDM4EGAAHSD17B10
SCHEMBL27757150 0.77 HSD17B3 (0.73) KDM4EGAAHSD17B10KMT2AALDH1A1
SCHEMBL13851555 0.77 HSD17B3 (0.64) TDP1KDM4EGAAHSD17B10KMT2A
SCHEMBL28499055 0.77 PRKDC (0.68) KDM4EGAAHSD17B10KMT2AALDH1A1
SCHEMBL26770692 0.76 PDE2A (0.57) KDM4EGAAHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119744118-A Herbicidal composition 拜耳公司 2025-04-01 CN claimed
CN-119677410-A Herbicidal compositions comprising azine compounds 巴斯夫欧洲公司 2025-03-21 CN claimed
CN-117203324-A Novel yeast strains and their use in controlling plant pathogens 爱农创投有限公司 2023-12-08 CN claimed
CN-112111560-B DNA nanosphere and preparation method and application thereof 深圳华大智造科技股份有限公司 2023-07-25 CN claimed
CN-112955011-B Compositions comprising pyridine carboxylic acid herbicides with photosystem II and optionally HPPD inhibitor herbicides 科迪华农业科技有限责任公司 2023-06-02 CN claimed
CN-114460808-A Photosensitive resin composition, color filter and display device using same 住华科技股份有限公司 2022-05-10 CN claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
CN-122059876-A Substituted quinoline compound, preparation method thereof, weeding composition and application 青岛清原化合物有限公司 2026-05-19 CN disclosed
CN-116056572-B Oil-based drift control composition 蓝宝迪有限公司 2026-05-15 CN disclosed
CN-222923266-U Protective coating and seawater hydrogen production device 江苏天合元氢科技有限公司 2025-05-30 CN disclosed
CN-120035584-A Substituted N-phenyluracils and salts thereof and their use as herbicidal agents 拜耳公司 2025-05-23 CN disclosed
US-20020102215-A1 Diagnostic/therapeutic agents NYCOMED IMAGING AS 2002-08-01 US disclosed
US-20020102217-A1 Diagnostic/therapeutic agents NYCOMED IMAGING AS 2002-08-01 US disclosed
US-6331289-B1 ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED NYCOMED IMAGING AS (NO) 2001-12-18 US disclosed
US-6264917-B1 MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT NYCOMED IMAGING AS (NO) 2001-07-24 US disclosed
US-6261537-B1 TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES NYCOMED IMAGING AS (NO) 2001-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020102215-A1 Diagnostic/therapeutic agents BID, FUS, FABP1 TDP1 1721/4885POLB 967/4885KDM4E 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.